HAERTLE, STEFAN,LECLAIR, STEPHANE,SHEBL, AMGAD,STEIDL, STEFAN
申请号：
CA2884124
公开号：
CA2884124A1
申请日:
2013.09.19
申请国别(地区):
CA
年份:
2014
代理人:
摘要：
The present invention provides anti-GM-CSF antibodies for use in the treatment of rheumatoid arthritis. Anti-GM-CSF antibodies, in particular MOR103, are administered to patients suffering from rheumatoid arthritis at dosages that are beneficial in a clinical setting.
